{
    "clinical_study": {
        "@rank": "107606", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo 320 mg daily for twelve weeks"
            }, 
            {
                "arm_group_label": "Anthocyanin", 
                "arm_group_type": "Experimental", 
                "description": "Drug: MEDOX (natural purified anthocyanin) anthocyanin 320 mg daily for twelve weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "Oxidative stress and inflammation are involved in the pathogenesis of non-alcoholic fatty\n      liver disease (NAFLD). Anthocyanins from different plant foods have been shown to improve\n      features of experimental NASH, such as oxidative stress, dyslipidemia, liver steatosis, and\n      inflammation in rodents. The purpose of this study is to investigate whether purified\n      anthocyanin supplementation beneficially alters oxidative, inflammatory, and apoptotic\n      biomarkers in adults with features of NAFLD."
        }, 
        "brief_title": "Purified Anthocyanin and Nonalcoholic Fatty Liver Disease", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Nonalcoholic Fatty Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Fatty Liver", 
                "Liver Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI [body weight divided by height squared (in kg/m2)] > 23,\n\n          -  lack of excessive alcohol ingestion confirmed by careful questioning by the primary\n             physician and dietitians (consumption of less than 70 g alcohol in female and 140 g\n             in male per week), and\n\n          -  the presence of two of the three following diagnostic criteria of the fatty liver\n             disease: increased hepatic echogenicity compared to the spleen or the kidneys,\n             blurring of liver vasculature and deep attenuation of the ultrasonographic signal.\n\n        Exclusion Criteria:\n\n          -  overuse of alcohol,\n\n          -  viral hepatitis,\n\n          -  type 1 or 2 diabetes,\n\n          -  gastrointestinal or connective diseases,\n\n          -  chronic pancreatitis,\n\n          -  liver cirrhosis,\n\n          -  kidney stones, or renal failure;\n\n          -  use of acetyl-salicylic acid or other antiplatelet drugs, statins of fibrates, oral\n             hypoglycemic drugs, nitrates, nonsteroidal antiinflammatory drugs, corticosteroids,\n             or drugs interfering with coagulation;\n\n          -  supplementation with vitamins or antioxidants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01940263", 
            "org_study_id": "SGU-02", 
            "secondary_id": "81372994"
        }, 
        "intervention": [
            {
                "arm_group_label": "Anthocyanin", 
                "intervention_name": "Anthocyanin", 
                "intervention_type": "Dietary Supplement", 
                "other_name": [
                    "MEDOX (natural purified anthocyanin)", 
                    "http://www.medox.no/english"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "oxidative stress", 
            "dyslipidemia", 
            "inflammation", 
            "apoptosis"
        ], 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "contact": {
                "email": "313743920@qq.com", 
                "last_name": "Peiwen Zhang, M. D.", 
                "phone": "86-18318540744"
            }, 
            "contact_backup": {
                "email": "626800557@qq.com", 
                "last_name": "Di Li, M. D.", 
                "phone": "86-15820231739"
            }, 
            "facility": {
                "address": {
                    "city": "Shaoguan", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "512005"
                }, 
                "name": "Shaoguan University"
            }, 
            "investigator": [
                {
                    "last_name": "Peiwen Zhang, M. D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Honghui Guo, Ph. D.", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Purified Anthocyanin on Oxidative and Inflammatory Markers in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial", 
        "overall_contact": {
            "email": "guohh1999@hotmail.com", 
            "last_name": "Honghui Guo, Ph. D.", 
            "phone": "86-751-8120167"
        }, 
        "overall_contact_backup": {
            "email": "313743920@qq.com", 
            "last_name": "Peiwen Zhang, M. D."
        }, 
        "overall_official": {
            "affiliation": "Sun Yat-sen University", 
            "last_name": "Wenhua Ling, Ph.D", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "plasma total antioxidant capacity; plasma levels of protein carbonyl groups", 
            "measure": "Biomarkers related to oxidative stress", 
            "safety_issue": "No", 
            "time_frame": "Twelve weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01940263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "tumor necrosis factor alpha; interleukin-8; high sensitive C-reactive protein", 
            "measure": "Biomarkers related to inflammation", 
            "safety_issue": "No", 
            "time_frame": "Twelve weeks"
        }, 
        "source": "Shaoguan University", 
        "sponsors": {
            "collaborator": {
                "agency": "Sun Yat-sen University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Shaoguan University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}